Realcan Pharmaceutical Group Co., Ltd. (002589.SZ) SHZ

3.93

+0.1(+2.61%)

Updated at January 14 03:04PM

Currency In CNY

Valuation

Market Cap4.47B
Enterprise Value5.91B
P/E Ratio-964.4
PEG Ratio5.5
Price/Sales Ratio0.61
Price/Book Ratio1.09
Enterprise/Revenue0.99
Enterprise/EBITDA30.78

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0
Operating Margin0

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue7.97B
Revenue/Share4.92
Gross Profit876.2M
EBITDA472.52M
Net Income20.62M
Diluted EPS0.01

Balance Sheet

Total Cash4.24B
Total Cash/Share2.86
Total Debt7.02B
Total Debt/Equity1.31
Current Ratio1.11
Book Value Per Share3.67

Price History

52-Week Change40.36
52-Week High4.69
52-Week Low2.51
Moving Average 50 Days3.34
Moving Average 200 Days3.05

Statistics

Average Volume91.57M
Shares Outstanding1.14B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0.1
Payout Ratio-24.91
Last Split Factor23:10
Last Split DateMay 15, 2017